Throughout Africa, 30 million pregnant women are exposed to malaria each year. Malaria in pregnancy carries increased risk of low birthweight, severe maternal anemia, maternal mortality, miscarriage, premature delivery, and stillbirth. To address malaria during pregnancy, the Roll Back Malaria Consortium advocates a three-pronged approach, one aspect of which is the delivery of intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP).
Treatment Uptake and Availability of Antimalarial Drugs for Intermittent Preventative Treatment in Pregnant Women in Malawi, a new report from the USAID | DELIVER PROJECT looks at Malawi to analyze the relationship between SP stockout rates and coverage of SP for intermittent preventative treatment of malaria in pregnant women. This analysis was performed to explore the relationship between stock availability and intervention coverage.
Download the publication at http://bit.ly/1SnTpwT
--
Anne Marie Hvid, PMP
Knowledge Management Advisor
USAID | DELIVER PROJECT
deliver.jsi.com
PHONE: 703.310.5256
WWW.JSI.COM
mailto:anne_marie_hvid@jsi.com